Leaflet PETINIMID 250mg soft capsules
Indicated for: epilepsy
Route of administration: oral
Substance: ethosuximide (antiepileptic)
ATC: N03AD01 (Nervous system | Antiepileptics | Succinimide derivatives)
This medicine may affect your ability to drive or use machines.
Dose adjustment may be needed in liver disease.
Dose adjustment may be needed in kidney disease.
This medicine may cause dizziness or vertigo.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Seek medical help if suicidal thoughts or major behavior changes occur.
This medicine may cause drowsiness or reduced alertness.
Ethosuximide is an anticonvulsant medication mainly used for the treatment of absence seizures in children and adults. It works by reducing abnormal electrical activity in the brain, helping to prevent absence seizures.
Ethosuximide is administered orally as capsules or syrup, according to the neurologist's instructions. The dose is adjusted individually, depending on the patient's response to treatment and any side effects.
Side effects may include nausea, vomiting, headaches, drowsiness, or, rarely, allergic reactions and liver or blood disorders. Medical monitoring is necessary throughout the treatment.
Ethosuximide is an effective option for controlling absence seizures, but its use requires careful medical supervision to manage possible side effects and ensure treatment effectiveness.
General data about PETINIMID 250mg
- Substance: ethosuximide
- Date of latest medicines list: 01-02-2023
- Product code: W03051001
- Concentration: 250mg
- Pharmaceutical form: soft capsules
- Quantity: 100
- Product type: Generic medicine
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Pharmaceutical forms available for ethosuximide
Concentrations available for ethosuximide
- 250mg
- 50mg/ml